Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Oct 29:17:863-870.
doi: 10.2147/OTT.S478613. eCollection 2024.

Pilot Feasibility and Safety Study of Hydrogen Gas Inhalation in Locally Advanced Head and Neck Cancer Patients

Affiliations
Clinical Trial

Pilot Feasibility and Safety Study of Hydrogen Gas Inhalation in Locally Advanced Head and Neck Cancer Patients

Imjai Chitapanarux et al. Onco Targets Ther. .

Abstract

Purpose: Hydrogen (H2) gas inhalation might alleviate acute radiotherapy toxicities by scavenging free radicals produced by ionizing radiation and anti-inflammatory properties. This study aimed to investigate the feasibility and safety of H2 gas inhalation during concurrent chemoradiotherapy (CCRT) in patients with locally advanced head and neck cancer (LAHNC).

Patients and methods: We designed a pilot prospective study combining CCRT with aerosol inhalation of H2 gas. Each patient was scheduled to receive daily intensity-modulated radiotherapy (IMRT) in 33 fractions on a weekday and six cycles of weekly chemotherapy. All patients inhaled H2 gas through a cannula or mask 1 hour per day, 1-2 hours before IMRT. The primary endpoint was the feasibility of H2 inhalation. Eighty percent of the patients who completed at least 20 applications of H2 gas inhalation were considered feasible. The secondary endpoints were safety profiles during H2 gas inhalation (vital signs and symptoms related to H2 gas inhalation) and acute toxicities during CCRT.

Results: We enrolled 10 patients with LAHNC between July 2023 and December 2023. All patients received 33 fractions of H2 gas inhalation on the same day as the IMRT. Vital signs during and at the end of H2 gas inhalation were stable in all patients. None of the 10 patients had hypertension or hypotension during any of the 33 inhalations. No adverse events related to H2 gas inhalation, such as cough, nasal bleeding, dizziness, headache, nausea, or vomiting, were reported. Grade 3 leukopenia was found in two patients (20%) during the 5th week of CCRT. Grade 2 radiation dermatitis and pharyngitis were found in three patients (30%).

Conclusion: H2 gas inhalation combined with CCRT is feasible and safe for patients with LAHNC.

Keywords: concurrent chemoradiotherapy; head and neck cancer; hydrogen gas.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no competing interest.

Figures

Figure 1
Figure 1
Maximum grade toxicities (NCI CTC version 5.0) during CCRT.

References

    1. Hirano SI, Aoki Y, Li XK, Ichimaru N, Takahara S, Takefuji Y. Protective effects of hydrogen gas inhalation on radiation-induced bone marrow damage in cancer patients: a retrospective observational study. Med Gas Res. 2021;11(3):104. doi:10.4103/2045-9912.314329 - DOI - PMC - PubMed
    1. Kim W, Lee S, Seo D, et al. Cellular Stress Responses in Radiotherapy. Cells. 2019;8(9):1105. doi:10.3390/CELLS8091105 - DOI - PMC - PubMed
    1. Buxton GV, Greenstock CL, Helman WP, Ross AB. Critical Review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (⋅OH/⋅O− in Aqueous Solution). J Phys Chem Ref Data. 1988;17(2):513–886. doi:10.1063/1.555805 - DOI
    1. Labiche LA, Grotta JC. Clinical trials for cytoprotection in stroke. NeuroRx. 2004;1(1):46–70. doi:10.1602/NEURORX.1.1.46 - DOI - PMC - PubMed
    1. Rahman MH, Jeong ES, You HS, Kim CS, Lee KJ. Redox-Mechanisms of Molecular Hydrogen Promote Healthful Longevity. Antioxidants. 2023;13:12. doi:10.3390/ANTIOX12050988 - DOI - PMC - PubMed

LinkOut - more resources